IDEAYA Biosciences Reports Third-Quarter 2026 Financial Results and Business Update
IDEAYA reported financial results for the quarter ended September 30, 2026, and provided a business update.
Story updates
11:01:59 AM UTC
SquawkNews
IDEAYA reported a net loss of $125.7M for Q3 2026, versus $112.5M in the prior quarter. Cash, cash equivalents and marketable securities were approximately $1.15B at September 30, 2026, down from $1.24B at June 30; cash runway guidance into 2030 is unchanged.Material DetailsContext by AI AnalystThi…
11:02:02 AM UTC
SquawkNews
IDEAYA Biosciences 3Q Loss/Shr $1.22 >IDYA
11:02:09 AM UTC
SquawkNews
IDEAYA Biosciences 3Q Rev $10.2M >IDYA
SOUTH SAN FRANCISCO, Calif., Nov. 3, 2026 // -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery, development and commercialization of targeted therapeutics, today reported financial results for the third quarter ended September 30…